BioSpace News Archive

Opening ceremony of new high-tech facility for the aseptic filling and freeze-drying of drug products.

Vectura was studying VR475, a drug-device combination consisting of budesonide delivered by Vectura’s proprietary nebulizer inhalation system as a treatment for adolescent and adult patients with severe uncontrolled asthma.

MilliporeSigma, a subsidiary of Merck KGaA, Darmstadt, Germany, handed out $30,000 to three graduate students for their research projects.

Three patients with quadriplegia were implanted with the BrainGate BCI, a sensor about the size of a baby aspirin. It can detect signals in the motor cortex. These were decoded and routed to a Bluetooth device that acts as a wireless mouse.

Bristol-Myers Squibb and LabCentral, a Cambridge, Mass.-based shared laboratory space, announced the two winners of the Bristol-Myers Squibb’s 2018 Golden Tickets for LabCentral. Due to being a platinum sponsor, Bristol-Myers Squibb could choose up to two innovative life science companies per year for Golden Tickets. This covers the cost of one lab bench for one year at LabCentral’s facility at Kendall Square in Cambridge.

Peer review has a long history behind it, and it has since become synonymous with the scientific method. Ever since its original inception in the 18th century, the peer review process has undergone many changes in its evolution to what it is now.

The U.S. Food and Drug Administration will update its review process for the approval of medical devices in the wake of a report that showed more than 80,000 injuries have been associated with medical devices for pain management since 2008.

REGENXBIO grants Rocket exclusive, worldwide rights to NAV AAV9 for the development and commercialization of treatments for Danon Disease

Preclinical Data Package Shows Dose-Dependent Survival, Functional, Structural, and Molecular Benefits with No Safety or Tolerability Issues Observed

This completes MDxHealth’s state licensing requirements for SelectMDx